In this study, disruption of intestinal HIF2α in mice reduced intestinal and circulating ceramide levels during high-fat diet feeding (most notably C16:0 ceramides), accompanied by reductions in body weight gain and hepatic steatosis, and improvements in systemic insulin sensitivity [224]. This evidence concerns the gene INS and fatty liver disease.